AG Coalition Reaches $17.85M Settlement In Generic Drug Pricing Antitrust Litigation

Source: The State AG Report

State: Connecticut, Multistate

Industry: Healthcare, Pharmaceuticals

Area of Law: Consumer Protection

• A coalition of 48 AGs led by Connecticut AG William Tong reached separate settlements with Lannett Company, Inc. ("Lannett") and Bausch Health US, LLC/Bausch Health Americas, Inc. ("Bausch") in generic-drug antitrust litigation.
• The states allege the companies participated in long-running conspiracies to fix prices and otherwise restrain competition in the generic drug market, including through coordination with competitors.
• Under the terms of the settlements—subject to court approval—Lannett will pay $13.77 million toward restitution and costs and agrees to a 10-year antitrust compliance program; Bausch will pay $4.08 million toward restitution and costs and must maintain an antitrust compliance policy and conduct annual antitrust training for four years. Both companies must provide reasonable cooperation with the states